Scilex Holding (SCLX) Equity Ratio (2020 - 2026)

Scilex Holding (SCLX) posted quarterly Equity Ratio of 0.87 for Q1 2026, up 67.69% year-over-year from 0.52 in Q1 2025, and down 51.99% on a QoQ basis from 0.57 in Q4 2025.

Scilex Holding (SCLX) Equity Ratio (2020 - 2026) Analysis & Trends

Scilex Holding (SCLX) has reported Equity Ratio for 7 consecutive years, with 0.87 the latest figure, recorded in Q1 2026.

  • In Q1 2026, Equity Ratio rose 67.69% year-over-year to 0.87; the TTM figure through Mar 2026 stood at 0.87 (up 67.69% YoY), while the FY2025 annual figure was 0.57, up 72.53% from the prior year.
  • Equity Ratio came in at 0.87 for Q1 2026 at Scilex Holding, down from 0.57 in the prior quarter.
  • The five-year high for Equity Ratio was 0.42 in Q4 2022, with the low at 2.97 in Q2 2025.
  • Average Equity Ratio over 5 years is 1.46, with a median of 1.77 recorded in 2022.
  • The largest YoY upside for Equity Ratio was 114.58% in 2022 against a maximum downside of 3111.89% in 2022.
  • Year by year, Equity Ratio stood at 0.42 in 2022, then plunged by 507.58% to 1.71 in 2023, then dropped by 21.41% to 2.07 in 2024, then soared by 72.53% to 0.57 in 2025, then slumped by 51.99% to 0.87 in 2026.
  • According to Business Quant data, Equity Ratio over the past three periods registered 0.87, 0.57, and 0.64 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Ratio (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn 0.27
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 0.40
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn -0.05
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn -
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn 0.36
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 0.10
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 0.42
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn 0.43
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Scilex Holding 54.30 Mn -95.62 Mn 4.15 Mn -0.87

Historic Data

Download Data
DateValue
Mar 31, 2026 -0.87
Dec 31, 2025 -0.57
Sep 30, 2025 -0.64
Jun 30, 2025 -2.97
Mar 31, 2025 -2.68
Dec 31, 2024 -2.07
Sep 30, 2024 -2.10
Jun 30, 2024 -2.05
Mar 31, 2024 -2.08
Dec 31, 2023 -1.71
Sep 30, 2023 -2.02
Jun 30, 2023 0.08
Mar 31, 2023 0.13
Dec 31, 2022 0.42
Sep 30, 2022 -2.26
Jun 30, 2022 -1.77
Mar 31, 2022 -1.64
Dec 31, 2021 -2.87
Sep 30, 2021 -0.07
Jun 30, 2021 -0.06